Effect of Interferon Beta-1a SC 44 µg Three Times Weekly (Tiw) (Rebif) and Dimethyl Fumarate (DMF, Tecfidera) on Infections and Lymphocytes in Patients 50 Years or Older From a Single Center Chart Review
Phase of Trial: Phase IV
Latest Information Update: 14 Aug 2018
At a glance
- Drugs Dimethyl fumarate (Primary) ; Interferon beta-1a (Primary)
- Indications Multiple sclerosis
- Focus Therapeutic Use
- Sponsors EMD Serono Research & Development Institute
- 03 Aug 2018 Status changed from recruiting to completed.
- 09 Feb 2018 Planned End Date changed from 31 Dec 2017 to 31 Jul 2018.
- 09 Feb 2018 Planned primary completion date changed from 31 Dec 2017 to 31 Jul 2018.